> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Beyond Air Submits PMA for LungFit PH
- URL: https://www.fdaweb.com/beyond-air-submits-pma-for-lungfit-ph/
- Published: 2020-11-11T12:00:00.000Z
- Updated: 2026-09-14T16:36:04.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5148061

Beyond Air says it has submitted a PMA application to FDA for its LungFit PH to treat persistent pulmonary hypertension of the newborn. A company [statement](https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=newssearch&cd=&cad=rja&uact=8&ved=0ahUKEwjY34Hu7frsAhUxrFkKHWcVD744ChDF9AEINzAB&url=http%3A%2F%2Fwww.globenewswire.com%2Fnews-release%2F2020%2F11%2F11%2F2124653%2F0%2Fen%2FBeyond-Air-Submits-Premarket-Approval-Application-to-FDA-for-LungFit-PH-to-Treat-Persistent-Pulmonary-Hypertension-of-the-Newborn.html&usg=AOvVaw1PGFP2i9Zpcb8cXJ1TwEnP) describes LungFit as a cylinder-free, plastic flow nitric oxide generator and delivery system that could potentially replace large, high-pressure nitric oxide cylinders, providing what the company says are significant advantages in hospitals such as reducing inventory and storage requirements and improving overall safety.